| 1 |
Costunolide inhibits pulmonary fibrosis via regulating NF-kB and TGF-beta(1)/Smad(2)/Nrf(2)-NOX4 signaling pathways
Liu B, Rong YM, Sun D, Li WW, Chen H, Cao B, Wang TY
Biochemical and Biophysical Research Communications, 510(2), 329, 2019 |
| 2 |
Heterologous biosynthesis of costunolide in Escherichia coli and yield improvement
Yin H, Zhuang YB, Li EE, Bi HP, Zhou W, Liu T
Biotechnology Letters, 37(6), 1249, 2015 |
| 3 |
Potential Anti-Cancer Activities and Mechanisms of Costunolide and Dehydrocostuslactone
Lin XJ, Peng ZX, Su CQ
International Journal of Molecular Sciences, 16(5), 10888, 2015 |
| 4 |
Microbial transformation of dehydrocostuslactone and costunolide by Mucor polymorphosporus and Aspergillus candidus
Ma XC, Zheng H, Guo DA
Enzyme and Microbial Technology, 40(5), 1013, 2007 |
| 5 |
Costunolide inhibits interleukin-1 beta expression by down-regulation of AP-1 and MAPK activity in LPS-stimulated RAW 264.7 cells
Kang JS, Yoon YD, Lee KH, Park SK, Kim HM
Biochemical and Biophysical Research Communications, 313(1), 171, 2004 |
